相关实验视频

Updated: Jul 14, 2025

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

我们能不能阻止一个心脏破碎:心脏重编程的胜利和挑战

Brian Spurlock¹, Jiandong Liu¹, Li Qian¹

¹McAllister Heart Institute, Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.

Current opinion in genetics & development

|October 5, 2023

概括

研究人员正在推进心脏重编程,以在受伤后再生心肌. 这一领域对治疗心血管疾病充满希望,特别是最近相关死亡率的增加.

科学领域:

心血管研究研究心血管研究
再生医学是一种再生医学.
分子生物学分子生物学

背景情况:

缺血性心脏损伤导致不可逆转的肌肉损伤和痕.
由于COVID-19的流行,应对心血管疾病死亡率的紧迫性增加了.
心脏重编程为再生受损的心肌提供了一个潜在的策略.

研究的目的:

审查心脏重编程策略的最新创新.
探索心脏重编程的潜在机制.
讨论心脏再生的因子传递技术的进展.

主要方法:

对新型重编程策略的文献综述.
分析关于重编程机制的当前研究.
评估新兴技术,用于将基因传递到心脏细胞中.

主要成果:

在开发新的重编程技术方面取得了重大进展.
对驱动心脏再生的分子通路的洞察力正在出现.
正在开发用于提供重编程因子的创新方法.

结论:

心脏重编程是一个快速发展的领域,具有显著的治疗潜力.
需要进一步的研究来将这些发现转化为心血管疾病的临床应用.
开发一个全面的重编程模型可以指导未来的研究方向.

更多相关视频

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

相关概念视频

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...